Bovine serum albumin nanoparticles induce histopathological changes and inflammatory cell recruitment in the skin of treated mice
da Silva, N.Ingrid.Oliveira.; Salvador, E.Aparecido.; Rodrigues Franco, I.; de Souza, G.Augusto.Pires.; de Souza Morais, S.Maria.; Prado Rocha, R.; Dias Novaes, Rômulo.; Paiva Corsetti, Pícia.; Malaquias, L.Cosme.Cotta.; Leomil Coelho, L.Felipe.
Biomedicine and PharmacoTherapy 107: 1311-1317
ISSN/ISBN: 0753-3322 PMID: 30257346 DOI: 10.1016/j.biopha.2018.08.106
Albumin is a natural, biocompatible, biodegradable and nontoxic polymer and due to these features, nanoparticles made of albumin are a good system for drug or antigen delivery. Polymeric nanoparticles are being widely explored as new vaccines platforms due to the capacity of those nanoparticles to prime the immune system by providing sustained release of the antigen after injection. Biodegradable nanoparticles associated with proteins represent a promising method for in vivo delivery of vaccines. In our previous studies, bovine serum albumin nanoparticles (BSA-NPs) were identified as a promising system for in vivo delivery of microbial antigens. The aim of this work was to show the effect of BSA-NPs on skin after nanoparticles administration. The pro-inflammatory activity of BSA-NPs was evaluated using in vivo models. BSA-NPs are easily uptake by macrophagic RAW 264.7 and BHK-21 cells without any significant cytotoxicity. Histological examination of skin sections from BSA-NPs-treated mice revealed intense cellular infiltration, increased skin thickness, follicular hypertrophy, vascular congestion and marked collagenesis. Mice immunized with recombinant non-structural protein 1 (rNS1) from Dengue virus 1 and BSA-NPs showed a high seroconversion rate if compared to animals immunized only with rNS1. Therefore, the effect of BSA-NPs on skin after BSA-NPs administration has a biotechnological relevance to the rational design of vaccine formulations based on albumin nanocarriers. However in the next years future studies should be carried out to best characterize the effect of BSA-NPs on dendritic cells and establish the role of these nanoparticles as a new vaccine platform for infectious diseases or cancer.